Leukemia PBMC

All filters

Format

Format

Format
Volume

Volume

Volume
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot # / SO#

Start typing to see matching Lot # / SO#.

Patient ID

Start typing to see matching Patient ID.

26 lots match
26 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Leukemia PBMC 78953 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel, Rituximab, Cyclophosphamide, Vincristine Leukemia Ukraine 2026 — — — — — — — — — 212080PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo24.02NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78952 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel, Rituximab, Cyclophosphamide, Vincristine Leukemia Ukraine 2026 — — — — — — — — — 212079PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo24.02NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78955 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel, Rituximab, Cyclophosphamide, Vincristine Leukemia Ukraine 2026 — — — — — — — — — 212082PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo24.02NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78954 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel, Rituximab, Cyclophosphamide, Vincristine Leukemia Ukraine 2026 — — — — — — — — — 212081PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo24.02NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78956 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel, Rituximab, Cyclophosphamide, Vincristine Leukemia Ukraine 2026 — — — — — — — — — 212083PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo24.02NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78933 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212111PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78935 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212113PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78934 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212112PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78937 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212115PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78936 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212114PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78938 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212116PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78939 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications, Rituximab, Bendamustine, Dexamethasone Leukemia Ukraine 2026 — — — — — — — — — 212117PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo26.15NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78830 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Losartan Leukemia Ukraine 2026 — — — — — — — — — 212161PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo23.32NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78829 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Losartan Leukemia Ukraine 2026 — — — — — — — — — 212160PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo23.32NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78832 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Losartan Leukemia Ukraine 2026 — — — — — — — — — 212163PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo23.32NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78831 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Losartan Leukemia Ukraine 2026 — — — — — — — — — 212162PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo23.32NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78833 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Losartan Leukemia Ukraine 2026 — — — — — — — — — 212164PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo23.32NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78847 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Leukemia Ukraine 2026 — — — — — — — — — 212203PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo29.53NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78846 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Leukemia Ukraine 2026 — — — — — — — — — 212202PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo29.53NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78849 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Leukemia Ukraine 2026 — — — — — — — — — 212205PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo29.53NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78848 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Leukemia Ukraine 2026 — — — — — — — — — 212204PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo29.53NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 78850 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Leukemia Ukraine 2026 — — — — — — — — — 212206PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo29.53NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 79342 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine, Rituximab, Cyclophosphamide, Fludarabine Leukemia Ukraine 2026 — — — — — — — — — 212295PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo25.33NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 79343 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine, Rituximab, Cyclophosphamide, Fludarabine Leukemia Ukraine 2026 — — — — — — — — — 212296PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo25.33NoNoNoStoredIn Stock
$1,580
Leukemia PBMC 79345 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine, Rituximab, Cyclophosphamide, Fludarabine Leukemia Ukraine 2026 — — — — — — — — — 212298PBMC10M cellsLeukemiaChronic Lymphocytic LeukemiaNo25.33NoNoNoStoredIn Stock
$1,580

Showing 1–25 of 26 lots

About Leukemia PBMC

Leukemia PBMC are sourced from consented donors with documented leukemia. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Leukemia research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Leukemia
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Processing specifications

Anticoagulant
Confirmed per lot on request
Isolation
Density-gradient centrifugation (SepMate™); optional RBC lysis
Processing window
Processed within ~24 hours of collection unless otherwise stated
Cryopreservation
Cryopreservation medium with 10% DMSO; controlled-rate freezing (−1 °C/min)
Storage
Vapor-phase liquid nitrogen
Count and viability
Automated dual-fluorescence cell counter; cells per vial listed per lot
Aliquot sizes
5 × 10⁶ cells (vial)1 × 10⁷ cells (vial)5 × 10⁷ cells (vial)2 × 10⁹ cells (bulk vials)

From Sanguine's processing protocols. View protocols

Donor and clinical data in these lots

Fields recorded on the 26 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
26 of 26 lots
Age
26 of 26 lots
Race
26 of 26 lots
BMI
26 of 26 lots

Clinical history

Primary diagnosis
26 of 26 lots
Current medications
26 of 26 lots
Allergies
26 of 26 lots
Infectious disease history
26 of 26 lots

Collection

Collection date
26 of 26 lots
Country of collection
26 of 26 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Leukemia PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information